Tuesday, January 27, 2026 | 09:11 AM ISTहिंदी में पढें
Fischer Medical Ventures Ltd
Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended December 31 2025 And To Transact Any Other Matter As May Be Specified In The Agenda.
12:01 PM, 23rd Jan 2026
Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 inter alia to consider and approve The unaudited Standalone and Consolidated financial results of the Company for the quarter ended December 31 2025 and to transact any other matter as may be specified in the agenda.